Thyrotoxicosis

The Lancet

Volumn 379, Issue 9821, 2012, Pages 1155-1166

  Franklyn, Jayne A ^a   Boelaert, Kristien ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; CARBIMAZOLE; LIOTHYRONINE; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN; THYROTROPIN RECEPTOR; THYROXINE;

AGRANULOCYTOSIS; ANCA ASSOCIATED VASCULITIS; APLASTIC ANEMIA; ARTHRALGIA; ARTHRITIS; CHOANA ATRESIA; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DRUG DOSE REDUCTION; DRUG SAFETY; ENVIRONMENTAL FACTOR; FEVER; FULMINANT HEPATIC FAILURE; GENETIC SUSCEPTIBILITY; GRANULOCYTOPENIA; GRAVES DISEASE; HEART ATRIUM FIBRILLATION; HORMONE RELEASE; HUMAN; HYPERTHYROIDISM; HYPOGLYCEMIA; HYPOPROTHROMBINEMIA; LABORATORY DIAGNOSIS; LOW DRUG DOSE; META ANALYSIS; NAUSEA AND VOMITING; PATIENT COMPLIANCE; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; QUALITY OF LIFE; REMISSION; SKIN APLASIA; SMELLING DISORDER; TASTE DISORDER; TERATOGENICITY; THROMBOCYTOPENIA; THYROIDECTOMY; THYROIDITIS; THYROTOXICOSIS; TOXIC HEPATITIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; URTICARIA;

EID: 84859102483     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60782-4     Document Type: Conference Paper

References (141)

1. SH Golden, KA Robinson, I Saldanha, B Anton, PW Ladenson Clinical review: prevalence and incidence of endocrine and metabolic disorders in the United States: a comprehensive review J Clin Endocrinol Metab 94 2009 1853 1878
2. WM Tunbridge, DC Evered, R Hall et al. The spectrum of thyroid disease in a community: the Whickham survey Clin Endocrinol (Oxf) 7 1977 481 493 (Pubitemid 8235965)
3. RW Flynn, TM Macdonald, AD Morris, RT Jung, GP Leese The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population J Clin Endocrinol Metab 89 2004 3879 3884 (Pubitemid 39071488)
4. S Wilson, JV Parle, LM Roberts et al. Prevalence of subclinical thyroid dysfunction and its relation to socioeconomic deprivation in the elderly: a community-based cross-sectional survey J Clin Endocrinol Metab 91 2006 4809 4816 (Pubitemid 44917312)
5. P Laurberg, PI Bulow, N Knudsen, L Ovesen, S Andersen Environmental iodine intake affects the type of nonmalignant thyroid disease Thyroid 11 2001 457 469
6. C Cerqueira, N Knudsen, L Ovesen et al. Association of iodine fortification with incident use of antithyroid medication - a Danish nationwide study J Clin Endocrinol Metab 94 2009 2400 2405
7. K Boelaert, PR Newby, MJ Simmonds et al. Prevalence and relative risk of other autoimmune diseases in subjects with autoimmune thyroid disease Am J Med 123 2010 183 189
8. N Manji, JD Carr-Smith, K Boelaert et al. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype J Clin Endocrinol Metab 91 2006 4873 4880 (Pubitemid 44917321)
9. OJ Brand, SC Gough Genetics of thyroid autoimmunity and the role of the TSHR Mol Cell Endocrinol 322 2010 135 143
10. OJ Brand, JC Barrett, MJ Simmonds et al. Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease Hum Mol Genet 18 2009 1704 1713
11. Z Wang, Q Zhang, J Lu et al. Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotopin receptor antibodies in Graves' disease and determination of its epitope using mass spectrometry and bioinformatics tools J Clin Endocrinol Metab 95 2010 4012 4020
12. BO Asvold, T Bjoro, TI Nilsen, LJ Vatten Tobacco smoking and thyroid function: a population-based study Arch Intern Med 167 2007 1428 1432 (Pubitemid 47052443)
13. MF Prummel, A Bakker, WM Wiersinga et al. Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European group on Graves' orbitopathy experience Eur J Endocrinol 148 2003 491 495 (Pubitemid 36622154)
14. K Wustmann, JP Kucera, A Zanchi et al. Activation of electrical triggers of atrial fibrillation in hyperthyroidism J Clin Endocrinol Metab 93 2008 2104 2108 (Pubitemid 351831522)
15. F Osman, JA Franklyn, RL Holder, MC Sheppard, MD Gammage Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study J Am Coll Cardiol 49 2007 71 81 (Pubitemid 46026889)
16. L Frost, P Vestergaard Alcohol and risk of atrial fibrillation or flutter: a cohort study Arch Intern Med 164 2004 1993 1998 (Pubitemid 39390555)
17. B Biondi, GJ Kahaly Cardiovascular involvement in patients with different causes of hyperthyroidism Nat Rev Endocrinol 6 2010 431 443
18. JA Franklyn, P Maisonneuve, MC Sheppard, J Betteridge, P Boyle Mortality after the treatment of hyperthyroidism with radioactive iodine N Engl J Med 338 1998 712 718 (Pubitemid 28115089)
19. JA Franklyn, MC Sheppard, P Maisonneuve Thyroid function and mortality in patients treated for hyperthyroidism JAMA 294 2005 71 80 (Pubitemid 41002841)
20. S Metso, P Jaatinen, H Huhtala, A Auvinen, H Oksala, J Salmi Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism J Clin Endocrinol Metab 92 2007 2190 2196 (Pubitemid 46997120)
21. DC Bauer, N Rodondi, KL Stone, TA Hillier Study of Osteoporotic Fractures Research Group Universities of California (San Francisco), Pittsburgh, Minnesota (Minneapolis); Kaiser Permanente Center for Health Research, Portland. Thyroid hormone use, hyperthyroidism and mortality in older women Am J Med 120 2007 343 349
22. CW Siu, CY Yeung, CP Lau, AW Kung, HF Tse Incidence, clinical characteristics and outcome of congestive heart failure as the initial presentation in patients with primary hyperthyroidism Heart 93 2007 483 487 (Pubitemid 46631516)
23. H Norrelund, KY Hove, E Brems-Dalgaard et al. Muscle mass and function in thyrotoxic patients before and during medical treatment Clin Endocrinol (Oxf) 51 1999 693 699 (Pubitemid 30050818)
24. AW Kung Clinical review: thyrotoxic periodic paralysis: a diagnostic challenge J Clin Endocrinol Metab 91 2006 2490 2495 (Pubitemid 44024605)
25. AG Gianoukakis, MJ Leigh, P Richards et al. Characterization of the anaemia associated with Graves' disease Clin Endocrinol (Oxf) 70 2009 781 787
26. C Carani, AM Isidori, A Granata et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients J Clin Endocrinol Metab 90 2005 6472 6479 (Pubitemid 41759302)
27. P Iglesias, O Devora, J Garcia, P Tajada, C Garcia-Arevalo, JJ Diez Severe hyperthyroidism: aetiology, clinical features and treatment outcome Clin Endocrinol (Oxf) 72 2010 551 557
28. K Boelaert, B Torlinska, RL Holder, JA Franklyn Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study J Clin Endocrinol Metab 95 2010 2715 2726
29. RH Lee, CA Spencer, JH Mestman et al. Free T4 immunoassays are flawed during pregnancy Am J Obstet Gynecol 200 2009 260 266
30. JA Franklyn What is the role of radioiodine uptake measurement and thyroid scintigraphy in the diagnosis and management of hyperthyroidism? Clin Endocrinol (Oxf) 72 2010 11 12
31. OE Okosieme, D Chan, SA Price, JH Lazarus, LD Premawardhana The utility of radioiodine uptake and thyroid scintigraphy in the diagnosis and management of hyperthyroidism Clin Endocrinol (Oxf) 72 2010 122 127
32. M Schott, D Hermsen, M Broecker-Preuss et al. Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial Clin Endocrinol (Oxf) 71 2009 566 573
33. EN Pearce Diagnosis and management of thyrotoxicosis BMJ 332 2006 1369 1373 (Pubitemid 44365354)
34. L Wartofsky, D Glinoer, B Solomon et al. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan, and the United States Thyroid 1 1991 129 135
35. AB Emiliano, L Governale, M Parks, DS Cooper Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008 J Clin Endocrinol Metab 95 2010 2227 2233
36. O Torring, L Tallstedt, G Wallin et al. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine - a prospective, randomized study. Thyroid Study Group J Clin Endocrinol Metab 81 1996 2986 2993
37. NN Patel, P Abraham, J Buscombe, MP Vanderpump The cost effectiveness of treatment modalities for thyrotoxicosis in a U.K. center Thyroid 16 2006 593 598 (Pubitemid 44066266)
38. DS Cooper Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies J Clin Endocrinol Metab 88 2003 3474 3481 (Pubitemid 37034479)
39. RS Bahn, HS Burch, DS Cooper et al. The role of propylthiouracil in the management of Graves' disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration Thyroid 19 2009 673 674
40. H Nakamura, JY Noh, K Itoh, S Fukata, A Miyauchi, N Hamada Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease J Clin Endocrinol Metab 92 2007 2157 2162 (Pubitemid 46997115)
41. P Abraham, A Avenell, CM Park, WA Watson, JS Bevan A systematic review of drug therapy for Graves' hyperthyroidism Eur J Endocrinol 153 2005 489 498 (Pubitemid 41556274)
42. S Razvi, B Vaidya, P Perros, SH Pearce What is the evidence behind the evidence-base? The premature death of block-replace antithyroid drug regimens for Graves' disease Eur J Endocrinol 154 2006 783 786 (Pubitemid 43997715)
43. BG Nedrebo, PI Holm, S Uhlving et al. Predictors of outcome and comparison of different drug regimens for the prevention of relapse in patients with Graves' disease Eur J Endocrinol 147 2002 583 589 (Pubitemid 35414555)
44. K Takata, N Amino, S Kubota et al. Benefit of short-term iodide supplementation to antithyroid drug treatment of thyrotoxicosis due to Graves' disease Clin Endocrinol (Oxf) 72 2010 845 850
45. WC Tsai, D Pei, TF Wang et al. The effect of combination therapy with propylthiouracil and cholestyramine in the treatment of Graves' hyperthyroidism Clin Endocrinol (Oxf) 62 2005 521 524 (Pubitemid 40646716)
46. FD El, CH Nielsen, SJ Bonnema, HC Hasselbalch, L Hegedus B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study J Clin Endocrinol Metab 92 2007 1769 1772 (Pubitemid 46997186)
47. A Allahabadia, J Daykin, RL Holder, MC Sheppard, SC Gough, JA Franklyn Age and gender predict the outcome of treatment for Graves' hyperthyroidism J Clin Endocrinol Metab 85 2000 1038 1042 (Pubitemid 32269346)
48. E Mazza, M Carlini, D Flecchia et al. Long-term follow-up of patients with hyperthyroidism due to Graves' disease treated with methimazole. Comparison of usual treatment schedule with drug discontinuation vs continuous treatment with low methimazole doses: a retrospective study J Endocrinol Invest 31 2008 866 872
49. P Vitti, T Rago, L Chiovato et al. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment Thyroid 7 1997 369 375 (Pubitemid 27295133)
50. K Takata, S Kubota, S Fukata et al. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily Thyroid 19 2009 559 563
51. JY Noh, S Yasuda, S Sato et al. Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs J Clin Endocrinol Metab 94 2009 2806 2811
52. L Harper, L Chin, J Daykin et al. Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease Clin Endocrinol (Oxf) 60 2004 671 675 (Pubitemid 38788072)
53. SA Rivkees, DR Mattison Ending propylthiouracil-induced liver failure in children N Engl J Med 360 2009 1574 1575
54. A de Rooij, JP Vandenbroucke, JW Smit, MP Stokkel, OM Dekkers Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis Eur J Endocrinol 161 2009 771 777
55. Royal College of Physicians Radioiodine in the management of benign thyroid disease 2007 Royal College of Physicians Publications London
56. RS Bahn Chair, HB Burch, DS Cooper et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists Thyroid 21 2011 593 646
57. S Hernandez-Jimenez, A Pachon-Burgos, CA Aguilar-Salinas et al. Radioiodine treatment in autoimmune hyperthyroidism: analysis of outcomes in relation to dosage Arch Med Res 38 2007 185 189 (Pubitemid 46080540)
58. K Boelaert, AA Syed, N Manji et al. Prediction of cure and risk of hypothyroidism in patients receiving 131I for hyperthyroidism Clin Endocrinol (Oxf) 70 2009 129 138
59. MA Walter, M Briel, M Christ-Crain et al. Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials BMJ 334 2007 514
60. SJ Bonnema, FN Bennedbaek, A Veje, J Marving, L Hegedus Continuous methimazole therapy and its effect on the cure rate of hyperthyroidism using radioactive iodine: an evaluation by a randomized trial J Clin Endocrinol Metab 91 2006 2946 2951 (Pubitemid 44271740)
61. SJ Bonnema, FN Bennedbaek, J Gram, A Veje, J Marving, L Hegedus Resumption of methimazole after 131I therapy of hyperthyroid diseases: effect on thyroid function and volume evaluated by a randomized clinical trial Eur J Endocrinol 149 2003 485 492 (Pubitemid 38063062)
62. F Bogazzi, C Giovannetti, R Fessehatsion et al. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal J Clin Endocrinol Metab 95 2010 201 208
63. MN Stan, RS Bahn Risk factors for development or deterioration of Graves' ophthalmopathy Thyroid 20 2010 777 783
64. SH Acharya, A Avenell, S Philip, J Burr, JS Bevan, P Abraham Radioiodine therapy (RAI) for Graves' disease (GD) and the effect on ophthalmopathy: a systematic review Clin Endocrinol (Oxf) 69 2008 943 950
65. M Abraham-Nordling, G Wallin, F Traisk et al. Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine Eur J Endocrinol 163 2010 651 657
66. L Bartalena Editorial: glucocorticoids for Graves' ophthalmopathy: how and when J Clin Endocrinol Metab 90 2005 5497 5499 (Pubitemid 41262322)
67. A Lai, L Sassi, E Compri et al. Lower dose prednisone prevents radioiodine-associated exacerbation of initially mild or absent Graves' orbitopathy: a retrospective cohort study J Clin Endocrinol Metab 95 2010 1333 1337
68. F Traisk, L Tallstedt, M Abraham-Nordling et al. Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131 J Clin Endocrinol Metab 94 2009 3700 3707
69. L Bartalena, L Baldeschi, A Dickinson et al. Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of GO Eur J Endocrinol 158 2008 273 285 (Pubitemid 351404990)
70. JA Franklyn, P Maisonneuve, M Sheppard, J Betteridge, P Boyle Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: a population-based cohort study Lancet 353 1999 2111 2115 (Pubitemid 29278480)
71. LE Holm, P Hall, K Wiklund et al. Cancer risk after iodine-131 therapy for hyperthyroidism J Natl Cancer Inst 83 1991 1072 1077
72. S Metso, A Auvinen, H Huhtala, J Salmi, H Oksala, P Jaatinen Increased cancer incidence after radioiodine treatment for hyperthyroidism Cancer 109 2007 1972 1979 (Pubitemid 46744190)
73. Y Erbil, Y Ozluk, M Giris et al. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease J Clin Endocrinol Metab 92 2007 2182 2189 (Pubitemid 46997119)
74. H In, EN Pearce, AK Wong, JF Burgess, DB McAneny, JE Rosen Treatment options for Graves disease: a cost-effectiveness analysis J Am Coll Surg 209 2009 170 179
75. S Grodski, P Stalberg, BG Robinson, LW Delbridge Surgery versus radioiodine therapy as definitive management for Graves' disease: the role of patient preference Thyroid 17 2007 157 160 (Pubitemid 46365571)
76. SM Wilhelm, CR McHenry Total thyroidectomy is superior to subtotal thyroidectomy for management of Graves' disease in the United States World J Surg 34 2010 1261 1264
77. JA Sosa, PJ Mehta, TS Wang, L Boudourakis, SA Roman A population-based study of outcomes from thyroidectomy in aging Americans: at what cost? J Am Coll Surg 206 2008 1097 1105
78. HD Roher, PE Goretzki, P Hellmann, J Witte Complications in thyroid surgery. Incidence and therapy Chirurg 70 1999 999 1010 (in German).
79. US Masiukiewicz, GN Burrow Hyperthyroidism in pregnancy: diagnosis and treatment Thyroid 9 1999 647 652 (Pubitemid 29357905)
80. S Kuy, SA Roman, R Desai, JA Sosa Outcomes following thyroid and parathyroid surgery in pregnant women Arch Surg 144 2009 399 406
81. M Clementi, GE Di, M Cassina, E Leoncini, LD Botto, P Mastroiacovo Treatment of hyperthyroidism in pregnancy and birth defects J Clin Endocrinol Metab 95 2010 E337 E341
82. LK Millar, DA Wing, AS Leung, PP Koonings, MN Montoro, JH Mestman Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism Obstet Gynecol 84 1994 946 949 (Pubitemid 24360253)
83. JS Sheffield, FG Cunningham Thyrotoxicosis and heart failure that complicate pregnancy Am J Obstet Gynecol 190 2004 211 217 (Pubitemid 38156350)
84. N Momotani, JY Noh, N Ishikawa, K Ito Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism J Clin Endocrinol Metab 82 1997 3633 3636 (Pubitemid 27509348)
85. P Laurberg, C Bournaud, J Karmisholt, J Orgiazzi Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy Eur J Endocrinol 160 2009 1 8
86. M Abalovich, N Amino, LA Barbour et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 92 suppl 2007 S1 47
87. N Amino, H Tada, Y Hidaka Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease Thyroid 9 1999 705 713 (Pubitemid 29357915)
88. M Rotondi, C Cappelli, B Pirali et al. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy J Clin Endocrinol Metab 93 2008 3985 3988
89. RD Benhaim, TF Davies Increased risk of Graves' disease after pregnancy Thyroid 15 2005 1287 1290 (Pubitemid 41821764)
90. M Rotondi, B Pirali, S Lodigiani et al. The post partum period and the onset of Graves' disease: an overestimated risk factor Eur J Endocrinol 159 2008 161 165
91. JL Kuijpens, VJ Pop, HL Vader, HA Drexhage, WM Wiersinga Prediction of post partum thyroid dysfunction: can it be improved? Eur J Endocrinol 139 1998 36 43 (Pubitemid 28351233)
92. A Stagnaro-Green Clinical review 152: postpartum thyroiditis J Clin Endocrinol Metab 87 2002 4042 4047
93. JH Lazarus The continuing saga of postpartum thyroiditis J Clin Endocrinol Metab 96 2011 614 616
94. S Williamson, SA Greene Incidence of thyrotoxicosis in childhood: a national population based study in the UK and Ireland Clin Endocrinol (Oxf) 72 2010 358 363
95. SA Rivkees, A Szarfman Dissimilar hepatotoxicity profiles of propylthiouracil and methimazole in children J Clin Endocrinol Metab 95 2010 3260 3267
96. F Kaguelidou, C Alberti, M Castanet et al. Predictors of autoimmune hyperthyroidism relapse in children after discontinuation of antithyroid drug treatment J Clin Endocrinol Metab 93 2008 3817 3826
97. JA Lee, MM Grumbach, OH Clark The optimal treatment for pediatric Graves' disease is surgery J Clin Endocrinol Metab 92 2007 801 803
98. JD Boice Jr Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl JAMA 295 2006 1060 1062
99. C Ma, A Kuang, L Xie, G Liu Radioiodine treatment for pediatric Graves' disease Cochrane Database Syt Rev 16 2008 CD006294
100. SA Rivkees, C Sklar, M Freemark Clinical review 99: the management of Graves' disease in children, with special emphasis on radioiodine treatment J Clin Endocrinol Metab 83 1998 3767 3776
101. CH Read Jr, MJ Tansey, Y Menda A 36-year retrospective analysis of the efficacy and safety of radioactive iodine in treating young Graves' patients J Clin Endocrinol Metab 89 2004 4229 4233 (Pubitemid 39244416)
102. SA Rivkees, C Dinauer An optimal treatment for pediatric Graves' disease is radioiodine J Clin Endocrinol Metab 92 2007 797 800
103. JA Sosa, CT Tuggle, TS Wang et al. Clinical and economic outcomes of thyroid and parathyroid surgery in children J Clin Endocrinol Metab 93 2008 3058 3065
104. CT Tuggle, SA Roman, TS Wang et al. Pediatric endocrine surgery: who is operating on our children? Surgery 144 2008 869 877
105. MM Bjorndal, WK Sandmo, T Lu, R Jorde Prevalence and causes of undiagnosed hyperthyroidism in an adult healthy population. The Tromso study J Endocrinol Invest 31 2008 856 860
106. J Meyerovitch, P Rotman-Pikielny, M Sherf, E Battat, Y Levy, MI Surks Serum thyrotropin measurements in the community: five-year follow-up in a large network of primary care physicians Arch Intern Med 167 2007 1533 1538 (Pubitemid 47124184)
107. T Vadiveloo, PT Donnan, L Cochrane, GP Leese The thyroid epidemiology, audit, and research study (TEARS): the natural history of endogenous subclinical hyperthyroidism J Clin Endocrinol Metab 96 2011 E1 E8
108. PW Rosario Natural history of subclinical hyperthyroidism in elderly patients with TSH between 0.1 and 0.4 mIU/l: a prospective study Clin Endocrinol (Oxf) 72 2010 685 688
109. B Biondi, DS Cooper The clinical significance of subclinical thyroid dysfunction Endocr Rev 29 2008 76 131 (Pubitemid 351252748)
110. AR Cappola, LP Fried, AM Arnold et al. Thyroid status, cardiovascular risk, and mortality in older adults JAMA 295 2006 1033 1041
111. CT Sawin, A Geller, PA Wolf et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons N Engl J Med 331 1994 1249 1252 (Pubitemid 24333188)
112. N Ochs, R Auer, DC Bauer et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality Ann Intern Med 148 2008 832 845 (Pubitemid 351786932)
113. G Iervasi, S Molinaro, P Landi et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients Arch Intern Med 167 2007 1526 1532 (Pubitemid 47124183)
114. J Gussekloo, E van Exel, AJ de Craen, AE Meinders, M Frolich, RG Westendorp Thyroid status, disability and cognitive function, and survival in old age JAMA 292 2004 2591 2599 (Pubitemid 39577515)
115. JV Parle, JA Franklyn, KW Cross, SC Jones, MC Sheppard Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom Clin Endocrinol (Oxf) 34 1991 77 83
116. P Haentjens, MA Van, K Poppe, B Velkeniers Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies Eur J Endocrinol 159 2008 329 341
117. MD Gammage, JV Parle, RL Holder et al. Association between serum free thyroxine concentration and atrial fibrillation Arch Intern Med 167 2007 928 934 (Pubitemid 46762755)
118. E Murphy, CC Gluer, DM Reid et al. Thyroid function within the upper normal range is associated with reduced bone mineral density and an increased risk of nonvertebral fractures in healthy euthyroid postmenopausal women J Clin Endocrinol Metab 95 2010 3173 3181
119. DC Bauer, B Ettinger, MC Nevitt, KL Stone Risk for fracture in women with low serum levels of thyroid-stimulating hormone Ann Intern Med 134 2001 561 568 (Pubitemid 32245317)
120. LJ Greenlund, KS Nair, MD Brennan Changes in body composition in women following treatment of overt and subclinical hyperthyroidism Endocr Pract 14 2008 973 978
121. LM Roberts, H Pattison, A Roalfe et al. Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? Ann Intern Med 145 2006 573 581 (Pubitemid 46780936)
122. J Faber, IW Jensen, L Petersen, B Nygaard, L Hegedus, K Siersbaek-Nielsen Normalization of serum thyrotrophin by means of radioiodine treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal women Clin Endocrinol (Oxf) 48 1998 285 290 (Pubitemid 28137639)
123. JA Sgarbi, FG Villaca, B Garbeline, HE Villar, JH Romaldini The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities J Clin Endocrinol Metab 88 2003 1672 1677 (Pubitemid 36623386)
124. MI Surks, E Ortiz, GH Daniels et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management JAMA 291 2004 228 238 (Pubitemid 38082818)
125. M Helfand U.S. Preventive Services Task Force Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 140 2004 128 141
126. D Erickson, H Gharib, H Li, JA van Heerden Treatment of patients with toxic multinodular goiter Thyroid 8 1998 277 282 (Pubitemid 28198719)
127. JR Porterfield Jr, GB Thompson, DR Farley, CS Grant, ML Richards Evidence-based management of toxic multinodular goiter (Plummer's disease) World J Surg 32 2008 1278 1284
128. SJ Bonnema, H Bertelsen, J Mortensen et al. The feasibility of high dose iodine 131 treatment as an alternative to surgery in patients with a very large goiter: effect on thyroid function and size and pulmonary function J Clin Endocrinol Metab 84 1999 3636 3641 (Pubitemid 30645217)
129. B Nygaard, L Hegedus, P Ulriksen, KG Nielsen, JM Hansen Radioiodine therapy for multinodular toxic goiter Arch Intern Med 159 1999 1364 1368 (Pubitemid 29293600)
130. V Fatourechi, JP Aniszewski, GZ Fatourechi, EJ Atkinson, SJ Jacobsen Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study J Clin Endocrinol Metab 88 2003 2100 2105 (Pubitemid 36549883)
131. J Cohen-Lehman, P Dahl, S Danzi, I Klein Effects of amiodarone therapy on thyroid function Nat Rev Endocrinol 6 2010 34 41
132. S Basaria, DS Cooper Amiodarone and the thyroid Am J Med 118 2005 706 714 (Pubitemid 40897652)
133. KH Yiu, MH Jim, CW Siu et al. Amiodarone-induced thyrotoxicosis is a predictor of adverse cardiovascular outcome J Clin Endocrinol Metab 94 2009 109 114
134. AJ O'Sullivan, M Lewis, T Diamond Amiodarone-induced thyrotoxicosis: left ventricular dysfunction is associated with increased mortality Eur J Endocrinol 154 2006 533 536
135. F Bogazzi, L Bartalena, E Martino Approach to the patient with amiodarone-induced thyrotoxicosis J Clin Endocrinol Metab 95 2010 2529 2535
136. E Martino, M Safran, F Aghini-Lombardi et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy Ann Intern Med 101 1984 28 34 (Pubitemid 14088063)
137. D Conen, L Melly, C Kaufmann et al. Amiodarone-induced thyrotoxicosis: clinical course and predictors of outcome J Am Coll Cardiol 49 2007 2350 2355 (Pubitemid 46891714)
138. F Osman, JA Franklyn, MC Sheppard, MD Gammage Successful treatment of amiodarone-induced thyrotoxicosis Circulation 105 2002 1275 1277 (Pubitemid 34260414)
139. SG Houghton, DR Farley, MD Brennan, JA van Heerden, GB Thompson, CS Grant Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience World J Surg 28 2004 1083 1087 (Pubitemid 40109855)
140. M Williams, GP Lo Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique Thyroid 12 2002 523 525 (Pubitemid 34721551)
141. M Abraham-Nordling, O Törring, B Hamberger et al. Graves' disease: a long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs, radioiodine, or surgery Thyroid 15 2005 1279 1286 (Pubitemid 41821763)